ASCENTAGE PHARMA GROUP INTERNATIONAL |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.88 HKD | +1.71% |
|
+7.84% | -34.51% |
| 04-25 | Ascentage Pharma to Present Four Studies at US Oncology Meet | MT |
| 04-09 | Ascentage Pharma Chairman Boosts Stake in Firm | MT |
Chart calendar Ascentage Pharma Group International
701800b239bcbf47300a3f03c073.WxdtDeiAp0hCVqfBPHHkZxyU55DeTXooS5ou-IgltpQ.FyUYQKHw7CALFcqjTSegAmrjraKKGQhsD8lEvPtg88toSDQ7kfbdcS5g1A~d9cecdb6471d5470fce64abc3c1cb2c9
Upcoming events on Ascentage Pharma Group International
Past events on Ascentage Pharma Group International
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract#: 4569 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract #3223 |
| 08/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract#: 1971 |
| 26/03/2024 | Q4 2023 Earnings Release |
| 10/01/2024 18:00 | JPMorgan Healthcare Conference |
| 11/12/2023 23:45 | American Society of Hematology Meeting - Abstract: #869 |
| 11/12/2023 23:45 | American Society of Hematology Meeting - Abstract: #827 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract: #2925 |
| 11/12/2023 02:00 | American Society of Hematology Meeting - Abstract: #2840 |
| 10/12/2023 01:30 | American Society of Hematology Meeting - Abstract: #1798 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract: #2016 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract: #2925 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract: #4538 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract: #1900 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract#1504 |
| 08/12/2023 | American Society of Hematology Meeting - Abstract#4205 |
| 19/10/2023 | European Society for Medical Oncology Congress - Abstract#: 5586 |
| 19/10/2023 | European Society for Medical Oncology Congress - Abstract#: 5746 |
| 20/08/2023 | Q2 2023 Earnings Release |
| 05/06/2023 14:00 | American Society of Clinical Oncology Meeting - Abstract No : 7569 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 14,5 6,58 120.52% | 12,5 7,00 77.86% | 27,9 223 -87.48% | 210 226 -7.09% | 222 387 -42.58% | 300 |
|
EBITDA Million CNY | Released Forecast Spread | -538 -498 -7.93% | -612 0,00 - | -747 -843 11.37% | -767 -784 2.11% | -751 -761 1.34% | -743 |
|
EBIT Million CNY | Released Forecast Spread | -564 -567 0.6% | -639 -713 10.36% | -847 -649 -30.42% | -836 -817 -2.3% | -836 -792 -5.54% | -769 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -1 482 -719 -106.29% | -675 -729 7.35% | -832 -817 -1.88% | -887 -863 -2.83% | -933 -876 -6.44% | -834 |
|
Net income Million CNY | Released Forecast Spread | -1 481 -718 -106.35% | -678 -729 7.05% | -782 -820 4.6% | -883 -857 -3.01% | -926 -868 -6.62% | -809 |
|
EPS CNY | Released Forecast Spread | -7,09 -4,50 -57.67% | -3,14 -3,39 7.41% | -3,07 -2,93 -4.69% | -3,35 -3,25 -3.06% | -3,28 -3,02 -8.46% | -2,87 |
| Announcement Date | 29/03/20 | 31/03/21 | 21/03/22 | 22/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 S1 | 2023 S2 |
|---|---|---|---|
|
EPS CNY | Released Forecast Spread | -1,47 -1,24 -18.55% | -1,81 -1,82 0.55% |
| Announcement Date | 21/08/23 | 27/03/24 |
More events
Past sector events for Ascentage Pharma Group International
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6855 Stock
- Calendar Ascentage Pharma Group International
